DARE
Dare Bioscience·NASDAQ
--
--(--)
--
--(--)
9.08 / 10
Outperform
Sentiment is strong (9.08) and fund‑flow scores 7.17, with small‑cap inflows positive but medium to extra‑large flows negative. Analyst consensus is 100% Strong Buy from one firm, boasting a 100% historical win rate and a weighted rating of 10.99, reinforcing bullish expectations.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-02
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate100.0%
Is money flowing into or out of DARE?
- DARE holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 9.08/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
